StocksMarket.in

Tag "Speciality"

 Breaking News

For Sumitomo Chemicals India, speciality is the trump card

The key near-term trigger for Sumitomo Chemical is the manufacturing of technical grade active ingredients for its parent company PRO Only Highlights–  Quarterly performance largely backed by improved realisations–  Medium-term

Read Full Article

Sumitomo Chemicals India: The speciality edge

The key near-term trigger is the manufacturing of technical grade active ingredients for the parent company PRO Only Highlights–  Quarterly performance largely backed by improved realisations–  Medium-term triggers China plus

Read Full Article

Bulk Deals | BC India offloads more shares in Himadri Speciality, Tata Sons arm picks major stake in Tejas Networks

Cascade Capital, which comes under public shareholding, held 17.64 percent or 1,65,13,184 equity shares in Tejas Networks as of June 2021. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”);

Read Full Article

Navin Fluorine: Speciality chemicals and CRAMS to lead the way

Navin Fluorine has mandated a large consulting firm to look at the synergistic opportunity presented by speciality chemicals and CRAMS Image credit: Suneesh K PRO Only Highlights–  Quarterly performance largely

Read Full Article

Trade Spotlight: What should investors do with Jay Shree Tea, Speciality Restaurants and Sobha?

Stocks that were in focus include Jay Shree Tea, which rose nearly 9 percent to hit a 52-week high, Speciality Restaurants (gained nearly 11 percent), and Sobha (saw gains of

Read Full Article

Sun Pharma: Traction in speciality likely to sustain

Sun Pharma’s key specialty products, particularly Ilumya (plaque psoriasis) and Cequa (dry eye disease), held up well Anubhav Sahu

Read Full Article

Sun Pharma: Traction in speciality likely to sustain

Sun Pharma’s key specialty products, particularly Ilumya (plaque psoriasis) and Cequa (dry eye disease), held up well Anubhav Sahu

Read Full Article

SRF: Superior execution continues for speciality; add stock on decline

The bulk of SRF’s capex allocation in the medium term is dedicated to chemicals to gear up its capacity to

Read Full Article

Sun Pharma: Sustained traction in speciality to be a re-rating driver

Sun Pharma’s India business is expected to gain traction as sub-chronic and acute therapies pick up with the opening up

Read Full Article

Aarti Industries Q1: Speciality is uninspiring, but pharma a saviour

App Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ?15,000/- 1 Last Updated : Aug 14, 2020

Read Full Article

Sun Pharma’s steady India business and US speciality portfolio should help it do well in FY22

App Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ?15,000/- 1 Last Updated : Aug 03, 2020

Read Full Article

Himadri Speciality: Outcome of carbon black anti-dumping review a key event to watch

App Moneycontrol Pro’s Introductory subscription offer: 3 years @ Rs 1999. Use code PRO3YEAR 1 Last Updated : Jul 27,

Read Full Article

Pharma, FMCG and speciality chemicals likely to turn leaders in next 6 months: Mayuresh Joshi

As per the CANSLIM methodology, sectors where earnings should relatively hold up include pharma, FMCG and speciality chemicals, Mayuresh Joshi, Head- Equity

Read Full Article

#39;AI, pharma, speciality chemicals, telecom may lead broader market post COVID#39;

New market leaders will emerge who will adapt to new challenges created by this unprecedented impact on global economy. Historically,

Read Full Article

Speciality Chemicals: Do current valuations present an opportunity?

To view the full content of this article, you have to be a Pro: Subscribe to Moneycontrol Pro: What’s included:

Read Full Article

Archives